Welcome to CDC stacks | Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010. - 7448 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.
Filetype[PDF-1.59 MB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease--Advisory Committee on Immunization Practices (ACIP), 2011
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    August 11, 2011
    Source:
    MMWR. Morbidity and mortality weekly report. 2011; 60(30):1018-9.
    Description:
    In January 2011, the Food and Drug Administration lowered the approval age range for use of MenACWY-CRM (Menveo, Novartis Vaccines and Diagnostics), a quadrivalent meningococcal conjugate vaccine, to include persons aged 2 through 55 years. One other...
    Status:
    superseded
    File Type:
    Filetype[PDF - 72.15 KB]
  2. Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2013
    Personal Author:
    MacNeil, Jessica R.; Rubin, Lorry; McNamara, Lucy; Briere, Elizabeth C.; Clark, Thomas A.; Cohn, Amanda C.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    Jun 20 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(24):527-530.
    Description:
    During its October 2013 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended use of a third meningococcal conjugate vaccine, MenACWY-CRM (Menveo, Novartis), as an additional option for vaccinating infants aged 2 through 23 mon...
    File Type:
    Filetype[PDF - 146.37 KB]
  3. Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
    Personal Author:
    Rubin, Lorry; Cohn, Amanda; MacNeil, Jessica; Messonnier, Nancy;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    Jan 25 2013
    Source:
    MMWR Morb Mortal Wkly Rep. 2013; 62(3):52-54.
    Description:
    At its October 2012 meeting, the Advisory Committee on Immunization Practices (ACIP) voted to recommend vaccination against meningococcal serogroups C and Y for children aged 6 weeks through 18 months at increased risk for meningococcal disease. Meni...
    File Type:
    Filetype[PDF - 134.58 KB]
  4. Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Baker, Carol J.; Briere, Elizabeth Z.; Clark, Thomas A.; Cohn, Amanda C.; MacNeil, Jessica R.; Meissner, H. Cody; Messonnier, Nancy E.; Ortega-Sanchez, Ismael R.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Immunization and Respiratory Diseases (U.S.), Division of Bacterial Diseases.;
    Published:
    March 22, 2013
    Series:
    Morbidity and mortality weekly report. Recommendations and reports, v. 62, no. RR-2
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 62, no. RR-2
    Description:
    Meningococcal disease describes the spectrum of infections caused by Neisseria meningiditis, including meningitdis, bacteremia, and bacteremic pneumonia. Two quadrivalent meningococcal polysaccharide-protein conjugate vaccines that provide protection...
    Status:
    current
    File Type:
    Filetype[PDF - 25.30 MB]
  5. DBD bulletin ; issue 05, spring 2010
    Corporate Author:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases.
    Published:
    spring 2010
    Series:
    DBD bulletin ; issue 5
    Description:
    WHO Global Reference Center -- Partners for SURVAC -- Global Pneumococcal Strain Bank -- Communications & Observances -- Global Pertussis Surveillance -- Meetings, Publications & Awards.
    File Type:
    Filetype[PDF - 1.96 MB]